Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
This trial is active, not recruiting.
|Start date||September 2012|
|End date||December 2014|
|Trial identifier||NCT00716209, NUSIRB 04-116|
The proposal seeks to establish:
- A comprehensive compilation (database) of clinical information comprising clinical, histopathological, treatment and follow-up characteristics of past and future gastrointestinal cancer (GIC) cases in Singapore that can be shared by investigators. The characteristics will include clinical (eg age, sex, stage), histopathological (eg. grade, type), treatment (eg. treatment status, regimens) and outcome data (eg. survival, toxicity) from medical records.
- A collection (bank) of corresponding frozen and fixed tissue, blood and processed samples (enriched blood mononuclear cells, protein, RNA, DNA, tissue arrays) in Singapore that can be shared by the investigators.
- A gastrointestinal cancer co-operative group (GCCG) of clinicians and scientists researching prognostic and predictive markers in GIC, which will benefit from the multi-disciplinary knowledge, information and samples of its members.
- To characterise genetic polymorphisms related to Gastrointestinal cancer chemotherapy treatment in controls (healthy volunteers)
Patients with cancers of the gastrointestinal tract (eg. colorectal, gastric, pancreatic, esophageal)
Male or female participants at least 18 years old.
Inclusion Criteria: - Patients with cancers of the gastrointestinal tract (eg. colorectal, gastric, pancreatic, esophageal) Exclusion Criteria: - None
|Official title||Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers|
|Principal investigator||Ross Andrew Soo, MBBS|
Call for more information